Your Basket 0

 

Ordering Details

Cat Number:OASE00189
Size:100ug
Concentration:1 mg/mL
Price:£495.00
Quantity:
Shipping:£12.00

Document Links

Data Sheet

 

Dnmt3L, Monoclonal Antibody

Partner: Aviva Systems Biology

Applications:WB, IHC, ICC, IF, IP, AM
Species Reactivity:Human, Mouse
Dilutions:WB (1:1000), IHC (1:1000), ICC/IF (1:100); optimal dilutions for assays should be determined by the user.
Immunogen:Fusion protein amino acids 1-387 of human DNMT3L
Purification:Protein G Purified
Conjugation:Unconjugated
Description:Methylation of DNA at cytosine residues plays an important role in regulation of gene expression, genomic imprinting and is essential for mammalian development. Hypermethylation of CpG islands in tumor suppressor genes or hypomethylation of bulk genomic DNA may be linked with development of cancer. To date, 3 families of mammalian DNA methyltransferase genes have been identified which include Dnmt1, Dnmt2 and Dnmt3. Dnmt1 is constitutively expressed in proliferating cells and inactivation of this gene causes global demethylation of genomic DNA and embryonic lethality. Dnmt2 is expressed at low levels in adult tissues and its inactivation does not affect DNA methylation or maintenance of methylation. The Dnmt3 family members, Dnmt3a and Dnmt3b, are strongly expressed in ES cells but their expression is down regulated in differentiating ES cells and is low in adult somatic tissue (1-6). Studies show that DNMT3L regulates the activity of DNMT3A and DNMT3B and stimulates their catalytic activities (7). DNMT3L has specifically been linked to the process of carcinogenesis, thru its role in nuclear programming (8).
Shipping Conditions:Ship on cold packs
Usage:Research Use Only

 

Insight Biotechnology Ltd reserves the right to change pricing without notice